The physiological decline in the production and circulating levels of key endocrine hormones that occurs progressively with chronological aging. This systemic reduction impacts numerous bodily functions, including metabolism, bone density, muscle mass, and cognitive health. It is a natural, yet clinically significant, phenomenon observed in both men and women, such as the decreases in testosterone, estrogen, and growth hormone. Managing this depletion is central to longevity and healthspan optimization in clinical endocrinology.
Origin
This concept originates from the convergence of gerontology and endocrinology, describing the inevitable changes in the hypothalamic-pituitary-gonadal and somatotropic axes over time. The term is a clinical descriptor of a fundamental biological process inherent to the human aging trajectory. It reflects the gradual functional senescence of endocrine glands and their regulatory centers.
Mechanism
The mechanism involves a complex interplay of reduced glandular responsiveness, decreased pulsatile secretion patterns from the hypothalamus and pituitary, and alterations in hormone receptor sensitivity at the cellular level. For example, somatopause involves decreased growth hormone-releasing hormone (GHRH) release, leading to lower nocturnal growth hormone (GH) output. This cascade results in a reduced anabolic drive and a shift toward catabolic states, contributing to sarcopenia and frailty.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.